Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimodivir (VX-787) Phase 2b in Influenza A
NCT02342249Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of pimodivir in Influenza A (IAV), sponsored by Janssen Pharmaceutical. Started Dec 2014; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02342249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342249.